Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Forget about Agoracom and focus on PTSC management....

Obviously, if the BoD is going to increase the share price, the mere collecting and distribution of MMP Portfolio revenues doesn't really qualify.

This only leaves Holocom and PDSG.

Does it stand to reason that if either one or both show profitability, this will be reflected in the share price, and as such, any complaints about the BoD not generating shareholder value fail miserably and are thus moot?

It is appreciated that fingers might be pointed to certain write-downs, and in that event would simply request examples of companies with a 100% success rate for M&As.

.

.

.

Be well

8
Jul 07, 2010 01:17AM
9
Jul 07, 2010 03:56AM
9
Jul 07, 2010 09:19AM
6
Jul 07, 2010 10:31AM
7
Jul 07, 2010 12:55PM
4
Jul 07, 2010 01:59PM
9
Jul 07, 2010 05:06PM
15
Jul 07, 2010 05:50PM
9
Jul 07, 2010 06:06PM

Jul 07, 2010 06:58PM
11
Jul 07, 2010 07:10PM
3
Jul 07, 2010 07:20PM
9
Jul 07, 2010 07:45PM
8
Jul 07, 2010 08:08PM
2
Jul 07, 2010 08:34PM
8
Jul 07, 2010 10:00PM
3
Jul 08, 2010 11:05AM
9
Jul 08, 2010 12:14PM
Share
New Message
Please login to post a reply